154 related articles for article (PubMed ID: 19456986)
1. Tissue Resonance Interaction Method (TRIMprob) has the potential to be used alongside the recognized tests in the screening protocols for prostate cancer.
Gokce O; Sanli O; Salmaslioglu A; Tunaci A; Ozsoy C; Ozcan F
Int J Urol; 2009 Jun; 16(6):580-3. PubMed ID: 19456986
[TBL] [Abstract][Full Text] [Related]
2. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
[TBL] [Abstract][Full Text] [Related]
3. Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation.
Da Pozzo L; Scattoni V; Mazzoccoli B; Rigatti P; Manferrari F; Martorana G; Pietropaolo F; Belgrano E; Prezioso D; Lotti T; Villari D; Nicita G
BJU Int; 2007 Nov; 100(5):1055-9. PubMed ID: 17711511
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of prostate cancer by electromagnetic interaction.
Bellorofonte C; Vedruccio C; Tombolini P; Ruoppolo M; Tubaro A
Eur Urol; 2005 Jan; 47(1):29-37; discussion 37. PubMed ID: 15582246
[TBL] [Abstract][Full Text] [Related]
5. Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.
Shim HB; Lee SE; Park HK; Ku JH
Prostate Cancer Prostatic Dis; 2007; 10(3):250-5. PubMed ID: 17297501
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
7. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
8. Patients with low prostate-specific antigen levels (< or =4 ng/ml) would benefit from a twelve-core biopsy protocol for prostate cancer detection.
Thiesler T; Trinkler F; Horcic M; Willi N; Cathomas G; Hailemariam S
Urol Int; 2007; 78(4):318-22. PubMed ID: 17495489
[TBL] [Abstract][Full Text] [Related]
9. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
10. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
11. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
13. The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.
van den Bergh RC; Roobol MJ; Wolters T; van Leeuwen PJ; Schröder FH
BJU Int; 2008 Nov; 102(9):1068-73. PubMed ID: 18715246
[TBL] [Abstract][Full Text] [Related]
14. Percent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter study.
Jeong IG; Lee KH;
J Urol; 2008 Jan; 179(1):111-6. PubMed ID: 17997422
[TBL] [Abstract][Full Text] [Related]
15. Prostate screening in patients with 46,XY disorders of sex development--is it necessary?
Salmasi AH; Wisniewski AB; Novak TE; Gearhart JP; Migeon CJ; Lakshmanan Y
J Urol; 2008 Oct; 180(4):1422-5; discussion 1425-6. PubMed ID: 18710761
[TBL] [Abstract][Full Text] [Related]
16. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
Miyakubo M; Ito K; Yamamoto T; Takechi H; Ohi M; Suzuki K
Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
[TBL] [Abstract][Full Text] [Related]
17. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
Lawrentschuk N; Fleshner N
BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen.
Baltaci S; Süer E; Haliloğlu AH; Gokce MI; Elhan AH; Bedük Y
J Urol; 2009 Jan; 181(1):128-32. PubMed ID: 19012907
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Dwivedi SN; Hemal AK; Gupta NP
NMR Biomed; 2007 Aug; 20(5):505-11. PubMed ID: 17167820
[TBL] [Abstract][Full Text] [Related]
20. Anterior apical biopsy: is it useful for prostate cancer detection?
Orikasa K; Ito A; Ishidoya S; Saito S; Endo M; Arai Y
Int J Urol; 2008 Oct; 15(10):900-4; discussion 904. PubMed ID: 18657203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
